News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
73,297 Results
Type
Article (1916)
Company Profile (42)
Press Release (71339)
Section
Business (34478)
Career Advice (51)
Deals (4916)
Drug Delivery (7)
Drug Development (8647)
Employer Resources (6)
FDA (1525)
Job Trends (1843)
News (47398)
Policy (2451)
Tag
Academia (147)
Allergies (6)
Alliances (2572)
ALS (6)
Alzheimer's disease (112)
Antibody-drug conjugate (ADC) (8)
Approvals (1553)
Artificial intelligence (14)
Automation (1)
Bankruptcy (12)
Best Places to Work (1752)
BIOSECURE Act (2)
Biosimilars (8)
Biotechnology (20)
Bladder cancer (20)
Brain cancer (3)
Breast cancer (56)
Cancer (326)
Cardiovascular disease (10)
Career advice (45)
CAR-T (11)
Cell therapy (41)
Cervical cancer (3)
Clinical research (7575)
Collaboration (49)
Compensation (20)
COVID-19 (147)
CRISPR (3)
C-suite (7)
Cystic fibrosis (3)
Data (368)
Depression (2)
Diabetes (36)
Diagnostics (775)
Digital health (3)
Diversity, equity & inclusion (2)
Drug discovery (8)
Drug pricing (3)
Drug shortages (5)
Duchenne muscular dystrophy (17)
Earnings (30570)
Editorial (3)
Employer resources (5)
Events (9201)
Executive appointments (20)
FDA (1733)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (52)
Gene editing (9)
Generative AI (2)
Gene therapy (38)
GLP-1 (111)
Government (270)
Guidances (102)
Healthcare (2208)
Huntington's disease (1)
IgA nephropathy (5)
Immunology and inflammation (13)
Indications (4)
Infectious disease (157)
Inflammatory bowel disease (8)
Inflation Reduction Act (1)
Influenza (2)
Intellectual property (9)
Interviews (5)
IPO (3690)
Job creations (181)
Job search strategy (41)
Kidney cancer (1)
Labor market (8)
Layoffs (28)
Legal (421)
Liver cancer (8)
Lung cancer (56)
Lymphoma (26)
Management (2)
Manufacturing (31)
MASH (26)
Medical device (1803)
Medtech (1803)
Mergers & acquisitions (1297)
Metabolic disorders (95)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (3)
Neuropsychiatric disorders (2)
Neuroscience (151)
NextGen: Class of 2025 (504)
Non-profit (256)
Obesity (44)
Opinion (9)
Ovarian cancer (6)
Pain (11)
Pancreatic cancer (11)
Parkinson's disease (13)
Partnered (3)
Patents (10)
Patient recruitment (7)
Peanut (5)
People (2297)
Pharmaceutical (17)
Pharmacy benefit managers (1)
Phase I (1889)
Phase II (3056)
Phase III (3154)
Pipeline (564)
Policy (8)
Postmarket research (312)
Preclinical (685)
Press Release (1)
Prostate cancer (10)
Radiopharmaceuticals (26)
Rare diseases (33)
Real estate (274)
Recruiting (3)
Regulatory (1916)
Reports (8)
Research institute (235)
Resumes & cover letters (3)
Rett syndrome (1)
RSV (3)
Schizophrenia (8)
Series A (5)
Series B (6)
Service/supplier (2)
Sickle cell disease (4)
Special edition (4)
Sponsored (2)
Startups (150)
Stomach cancer (2)
Supply chain (12)
Tariffs (1)
Vaccines (39)
Venture capitalists (3)
Weight loss (27)
Women's health (2)
Worklife (1)
Date
Today (59)
Last 7 days (285)
Last 30 days (562)
Last 365 days (4665)
2025 (1734)
2024 (5036)
2023 (5587)
2022 (6666)
2021 (6883)
2020 (6311)
2019 (5045)
2018 (3915)
2017 (3891)
2016 (2833)
2015 (4146)
2014 (2775)
2013 (1899)
2012 (2111)
2011 (2302)
2010 (1891)
Location
Africa (36)
Alabama (5)
Arizona (11)
Asia (4563)
Australia (408)
California (891)
Canada (241)
China (67)
Colorado (43)
Connecticut (41)
Delaware (36)
Europe (10023)
Florida (111)
Georgia (36)
Idaho (1)
Illinois (69)
India (6)
Indiana (90)
Japan (31)
Kansas (18)
Kentucky (1)
Louisiana (4)
Maine (17)
Maryland (89)
Massachusetts (640)
Michigan (31)
Minnesota (49)
Missouri (6)
Montana (12)
Nevada (12)
New Hampshire (10)
New Jersey (291)
New York (305)
North Carolina (111)
Northern California (451)
Ohio (20)
Oregon (1)
Pennsylvania (190)
South America (89)
Southern California (348)
Tennessee (7)
Texas (102)
United States (3313)
Utah (27)
Virginia (13)
Washington D.C. (4)
Washington State (110)
Wisconsin (6)
73,297 Results for "53".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cardiac Dimensions Raises $53 Million Series E Financing
March 20, 2025
·
3 min read
Press Releases
IND Application for NTS071, Nutshell Therapeutics’ p53 Y220C Allosteric Reactivator, Received US FDA clearance
May 5, 2025
·
3 min read
Press Releases
SELLAS Unveils Breakthrough Preclinical Data Highlighting Efficacy of SLS009 in TP53 Mutated AML at the 2025 AACR Conference
April 28, 2025
·
6 min read
Press Releases
Frontier Medicines Unveils New Preclinical Data for FMC-220, a First-in-Class Covalent p53 Y220C Activator, at AACR 2025
April 29, 2025
·
4 min read
Weight loss
Roche Makes Another Obesity Play With Potential $5.3B Amylin Pact With Zealand
Roche and Zealand plan to study petrelintide as a monotherapy and in combination with CT-388, a dual agonist of the GLP-1 and GIP receptors that Roche picked up in its recent acquisition of Carmot Therapeutics.
March 12, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Vori Health Secures $53 Million in Series B Funding to Transform Value-Based Musculoskeletal Care
March 12, 2025
·
5 min read
Press Releases
Clinical Trials Support Services Market Size to Reach USD 53.71 Bn by 2034
February 26, 2025
·
1 min read
Press Releases
[Ad hoc announcement pursuant to Art. 53 LR] Roche continues good momentum into 2025 with 6% (CER) sales growth in the first quarter
April 24, 2025
·
20 min read
Press Releases
Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada
March 25, 2025
·
3 min read
Press Releases
NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.
February 21, 2025
·
4 min read
1 of 7,330
Next
